You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bendamustine HCI

Showing 1 - 25 of 311
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 1, 2020

Leukemia Trial in Houston (Bendamustine, Fludarabine, Rituximab)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 24, 2019

Binge-Eating Disorder Trial in New Haven (Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination, Placebo)

Active, not recruiting
  • Binge-Eating Disorder
  • Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
  • Placebo
  • New Haven, Connecticut
    Yale School of Medicine
Feb 18, 2022

Mantle-cell Lymphoma Trial (Polatuzumab, bendamustin und rituximab)

Not yet recruiting
  • Mantle-cell Lymphoma
  • Polatuzumab, bendamustin und rituximab
  • (no location specified)
May 11, 2023

CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

Active, not recruiting
  • CCND1 Positive
  • +2 more
  • Atlanta, Georgia
  • +2 more
Nov 2, 2022

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

Recruiting
  • Lymphoma
  • Beijing, China
  • +2 more
Oct 12, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 21, 2022

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Downey, California
  • +231 more
Jan 16, 2023

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

Follicular Lymphoma Trial (Bendamustine, Rituximab, Tazemetostat)

Not yet recruiting
  • Follicular Lymphoma
  • (no location specified)
Dec 15, 2022

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Waldenstrom Macroglobulinemia
  • Calgary, Alberta, Canada
  • +8 more
Nov 9, 2022

Postoperative Pain Trial in Japan (SyB P-1501, SyB P-1501 )

Terminated
  • Postoperative Pain
  • SyB P-1501
  • SyB P-1501 placebo
  • Nagakute, Aichi, Japan
  • +28 more
Nov 14, 2022

Mantle Cell Lymphoma Trial in Seoul (RB/RBAC alternating, RB)

Not yet recruiting
  • Mantle Cell Lymphoma
  • RB/RBAC alternating
  • RB
  • Seoul, Gangnam-Gu, Korea, Republic of
    Samsung Medical Center
Apr 18, 2022

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2022

Mantle Cell Lymphoma Trial in United States (Venetoclax, Bendamustine, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Urbana, Illinois
  • +9 more
Nov 10, 2022

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Jul 19, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Acalabrutinib (ACP-196)
  • +3 more
  • Chandler, Arizona
  • +156 more
Jun 2, 2022

Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)

Recruiting
  • Follicular Lymphoma (FL)
  • +2 more
  • Tucson, Arizona
  • +134 more
Jul 27, 2022